Biogen Inc (BIIB) Shares Surge 3.4% -- What GF Score of 72 Tells Investors

Biogen Inc (BIIB) shares surged 3.4% to $183.34, leading to a “fairly valued” verdict from GF Value™ despite being 8.6% undervalued compared to the $200.50 estimate. The company’s GF Score™ of 72/100 indicates solid potential, primarily driven by its perfect 10/10 Valuation score, though growth prospects are limited (2/10 G.F Rating). Insider selling activity of $0.7 million in the last three months suggests caution for potential investors.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin